Golden
UBiome

UBiome

Biotechnology microbial genomics company based in San Francisco

uBiome was founded in October 2012 by Jessica Richman and Zachary Apte, two scientists from the California Institute for Quantitative Biosciences. It is a privately held, citizen science startup that sequences the human microbiome.



The company's commercial products include:

  • SmartGut - a sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn's Disease, and ulcerative colitis. The test detect both beneficial and pathogenic microorganisms associated with these gut conditions.



  • SmartJane - a sequencing based women's health screening test, which genotypes all 19 clinically relevant strains of HPV, identified four common STDs (chlamydia, gonorrhea, syphilis, and mycoplasma genitalium), and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions. However, it does not screen for cancer and is not intended to replace traditional Pap smears or well woman visits.



  • SmartFlu - an upper respiratory test that analyzes nasal microbiome when a person experiences cold or flu symptoms. It detects bacteria and viruses associated with health conditions such as, the flu, common cold, and bacterial infections. This product is available by invite-only as of February 2019.



  • Explorer - a health and wellness product to understand the role that food and lifestyle can play in wellness.



In September 2018, uBiome announced that it will be supporting drug-discovery efforts using its technology at a new Cambridge, Massachusetts headquarters. It also raised $83 million in a Series C round of funding.

Timeline

April 26, 2019

uBiome offices raided by FBI

Investigation due to billing practices.

Funding rounds

2 Results
Funding round
Funding round
Funding round amount (USD)
Funding round amount (USD)
Funding type
Funding type
Funding round date
Funding round date
Investment
Investment

People

Name
Role
LinkedIn

Adam Schwartz

Investor



Adam Spector

Investor



Ahmed Dailami

Investor



Alexandra Carmichael

Employee



Andrew Crichton

Investor



Andy Warner

Investor



AngelList Syndicates Fund Manager

Investor



Ari Meisel

Advisor



Bill Tai

Investor



Brad Porteus

Investor



Brett Jackson

Investor



Brian Cain

Investor



Brian Dexheimer

Investor



Bryan Johnson

Investor



Bryant Detwiller

Investor



Carlos Betancourt Carrero

Employee



Charles Bergmeier

Employee



Cok Mudde

Investor



Colby Holliday

Employee



Cristobal Cuart

Investor



Daniel Almonacid

Employee



Daniel Curran

Investor



Daniel Dulitz

Investor



Daniel Kellmereit

Investor



Daniel Pepper

Advisor



Further reading

Title
Author
Link
Type
Date

uBiome is jumping into therapeutics with a healthy $83 million in Series C financing



Web



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References